A Prospective, Open‐Label, Post Marketing Study of the Safety and Effectiveness of a Hyaluronic Acid and Calcium Hydroxyapatite Hybrid Injectable
HA-CaHA and HA-CaHA-L are effective and well-tolerated for midface soft tissue augmentation, lasting up to 1 year.
Authors
- Graeme Kerson (ORCID: https://orcid.org/0009-0004-5988-424X)
- Andrew Schumacher (ORCID: https://orcid.org/0000-0002-0643-8009)
- Alessandro Gritti
- Malka Salomon
- Lea Elmaleh
Institutions
- AbbVie (United States) (US)
- Allergan (United Kingdom) (GB)
- Gruppo di Ricerca Geriatrica (IT)
- Allergan (United States) (US)
- AbbVie (United Kingdom) (GB)
Publication Details
- Journal
- Journal of Cosmetic Dermatology
- Published
- 2025-09-01
- DOI
- https://doi.org/10.1111/jocd.70430
- Citations
- 2
- Primary Topic
- Facial Rejuvenation and Surgery Techniques
- Type
- article
- Field-Weighted Citation Impact
- 4.01